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D
ietary patterns have long been recognized as a key factor
in the association of disease patterns and health out-
comes. Pellagra, as an example, was prevalent among the poor
in the American South in the early 1900s and was basically
eradicated with nutritious diets and vitamin-enriched flour.
1,2
Other conditions such as scurvy are well recognized as
associated with diet and malnutrition, and recognized cur-
rently in developing countries.
3 Similarly, the high intake of
dietary cholesterol and fats was found decades ago to be
associated with increased risks of cardiovascular disease.
4,5
These findings have led to public health interventions and
policies designed to improve dietary patterns in an effort to
promote health and prevent disease.
The dietary intake of salt and sodium represents another
major lifestyle and behavior associated with disease prevalence.
The associations of sodium intake and adverse cardiovascular
outcomes have long been recognized, with reduction in salt
consumption considered a major public health intervention.
Reduction in sodium intake is a recommended lifestyle modifi-
cation of the Seventh Report of the Joint National Committee on




with blood pressure lowering among hypertensives, both alone
and as a complement to medical treatment.
7
The information regarding the risks of high sodium intake
and the potential benefit of a lower sodium diet has been
conveyed effectively to the public. In a study of older Americans
regarding attitudes on lifestyle and blood pressure level, 90%
of the respondents reported that a reduction in salt intake was
effective for treating and controlling high blood pressure, with
14% indicating sodium restriction as the most effective lifestyle
factor.
8 However, with a society skeptical of strategies that fail
to yield proclaimed benefits, it is prudent for clinical investi-
gators and epidemiologists to quantify accurate risks and
benefits. In this issue of the Journal of General Internal
Medicine, Cohen and colleagues continue the debate regarding
the risks and benefits of salt intake.
9 In particular, the authors
assess cardiovascular disease and all-cause mortality in the
Third National Health and Nutrition Examination Survey
(NHANES III) determining modest and non-significant associ-
ation of sodium intake and higher mortality risks. Further,
they concluded from the analyses that higher sodium intake
was unlikely to be an independent predictor of high cardio-
vascular or all-cause mortality.
9
While the analyses are reasonable and take advantage of a
valuable epidemiologic data base, several issues should be
considered when evaluating the results. First, these results are
based on a secondary data analysis. While such results are
valuable in developing hypotheses, conclusions are better
based on randomized clinical trials.
10 The assessment of
sodium intake is another limitation of the study, as indicated
by the authors. The use of a single measure of sodium intake
as an indication of salt consumption may indeed not be
representative of the true diet. Likewise, this concern is
multiplied as there are no sodium excretion measures to
validate the intake values. A third issue regards the potential
sampling issues of the NHANES III, which was not designed
specifically for the measurement of sodium intake in the
population. While this is an excellent study cohort, inclusion
of individuals with varying geographic and cultural use of salt
may not be adequately sampled. These parameters were not
included in the statistical models.
When Alderman and colleagues presented earlier work in
1998 with similar findings using the first National Health and
Nutrition Examination Survey,
11 conflicting views were
expressed. The spirited exchange of letters identified many of
the limitations and cautions described with the current paper,
with the references to numerous epidemiological studies
reporting the benefits of salt reduction. Thus, the debate
continues. However, as the clinical guidelines for disease
management and policies regarding sodium are updated, it is
imperative these documents be based on actuate information.
While the debate is “healthy” for the progress of science, it can
be confusing when affecting prevention and disease manage-
ment strategies.
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